Art Clinic is establishing a Center of Excellence for Integrum’s OPRA[TM] Implant System
Art Clinic will provide treatment excellence using Integrum's OPRA™ Implant System and serve as a center for Training and Education for clinicians from around the world.
As the exclusive “Center of Excellence” in the Nordic countries, Art Clinic will provide treatment excellence using the OPRA™Implant System and serve as a center for Training and Education for clinicians from around the world.
As Professor Rickard Brånemark is based in San Francisco, Art Clinic will also provide a clinical base for him in Europe.
Art Clinic is a private hospital chain that was founded in 1999 and offers first-class care within orthopaedics, spinal surgery, plastic surgery, and physiotherapy. The clinics are very well equipped with ultra-modern medical equipment and operational theatres.
The medical equipment and operational theatres comply with both Swedish and EU legal requirements on function and safety. Art Clinic is today one of Sweden’s leading specialist clinics and holds a very high hospital standard.
Art Clinic offers both outpatient surgery, and more advanced surgical procedures which require post-operative overnight stays and observation/care. Today, Art Clinic is established in Gothenburg, Stockholm, Jönköping, and Uppsala.
“I am very happy to have a clinical platform at Art Clinic, which is a very professional organization with the highest standards in quality control and surgical facilities”, says Professor Rickard Brånemark, Chairman of the Board at Integrum AB.
“We are extremely pleased to announce that Art Clinic is establishing the Center of Excellence for the OPRA™ Implant System, and look forward to a mutually beneficial collaboration for many years to come”, says Maria Lopez, CEO at Integrum AB.
This disclosure contains information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 02-11-2020 09:00 CET. Integrum is listed on Nasdaq First North in Stockholm. Erik Penser is the Company's Certified Adviser.
For further information, please contact:
Maria Lopez, CEO
Cell. 0708-46 10 69
Email: maria.lopez@integrum.se
Certified Adviser:
Erik Penser Bank AB
Tel. +46 8 463 8000
Email: certifiedadviser@penser.se
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden with a U.S. subsidiary in San Francisco, CA. Since 1990 the OPRA™ Implant System has been helping individuals with amputations towards an improved quality of life. Thorough surgical experience gained over more than three decades from 500 surgeries in 14 countries has led to the development of Integrum’s system for bone-anchored prosthetics – a beneficial alternative to the traditionally used socket prosthesis.
The OPRA™ Implant System is the only FDA approved technology for above-knee, bone-anchored prosthetics available in the U.S. More information on the company and its innovative solutions for amputees can be found at www.integrum.se.